Division of Reproductive Health, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.
Division of Reproductive Health, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.
Womens Health Issues. 2021 Nov-Dec;31(6):560-566. doi: 10.1016/j.whi.2021.07.006. Epub 2021 Sep 9.
Emergency contraception (EC), including EC pills (ECPs) and the copper intrauterine device, can prevent pregnancy after sexual encounters in which contraception was not used or used incorrectly. The U.S. Selected Practice Recommendations for Contraceptive Use (U.S. SPR), initially released in 2013, provides evidence-based clinical recommendations on the provision of EC. The objective of this analysis was to assess the percentage of health care providers reporting frequent provision of select EC practices around the time of and after the release of the U.S. SPR.
We conducted two cross-sectional mailed surveys using different nationwide samples of office-based physicians and public-sector providers in 2013 and 2014 (n = 2,060) and 2019 (n = 1,420). We compared the percentage of providers reporting frequent provision of select EC practices by time period, overall, and by provider type.
In 2019, few providers frequently provided an advance prescription for ECPs (16%), an advance supply of ECPs (7%), or the copper intrauterine device as EC (8%), although 41% frequently provided or prescribed regular contraception at the same time as providing ECPs. Providers in 2019 were more likely than providers in 2013 and 2014 to provide or prescribe contraception at the same time as providing ECPs (adjusted prevalence ratio, 1.26; 95% confidence interval, 1.001-1.59) and to provide a copper intrauterine device as EC (adjusted prevalence ratio, 3.87; 95% confidence interval 2.10-7.15); there were no other significant differences by time period.
Few providers report frequent implementation of recommended EC practices. Understanding the barriers faced by providers and clinics in implementing these practices may improve access to EC.
紧急避孕(EC),包括 EC 丸(ECP)和铜宫内节育器,可在性行为中未使用或使用不当避孕后预防怀孕。美国选择的避孕使用实践推荐(U.S. SPR)于 2013 年首次发布,提供了关于提供 EC 的基于证据的临床建议。本分析的目的是评估在 U.S. SPR 发布前后,报告经常提供特定 EC 实践的医疗保健提供者的百分比。
我们在 2013 年和 2014 年(n=2060)以及 2019 年(n=1420)使用不同的全国性门诊医生和公共部门提供者样本进行了两次横断面邮寄调查。我们比较了报告经常提供特定 EC 实践的提供者的百分比,按时间段、总体和提供者类型进行比较。
2019 年,很少有提供者经常提供 ECP 的预先处方(16%)、预先供应 ECP(7%)或铜宫内节育器作为 EC(8%),尽管 41%的人在提供 ECP 的同时经常提供或开常规避孕处方。与 2013 年和 2014 年相比,2019 年的提供者更有可能在提供 ECP 的同时提供或开避孕处方(调整后流行率比,1.26;95%置信区间,1.001-1.59),并且更有可能提供铜宫内节育器作为 EC(调整后流行率比,3.87;95%置信区间,2.10-7.15);没有其他时间段的显著差异。
很少有提供者报告经常实施推荐的 EC 实践。了解提供者和诊所在实施这些实践方面面临的障碍可能会改善 EC 的可及性。